chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1. May 7 -  2nd dose  2. May 8 - Lymph Node swelled to golf ball size day after vaccine.   3. May 11 - Top of feet and lower legs started to burn and eventually spread to lower half of upper leg.  Same sensation in forearms from time to time, but not as severe as in legs.  Legs are constant.  Exacerbated by heat (outside temp, shower, etc.) 4. June 10 - Saw primary pyhsician (referred to Neurologist) 5. June 29 - Neurologist ruled out Neuropathy and said should pass over time 6. Still ongoing as of Sept 16 with no let-up
Can't breath; Back hurts; Cold-like symptoms; Sneezing; Coughing all night long; Back hurts - thinks it's her lungs; Pain more in chest; Chest pressure is worse/ Chest tightness; Blood pressure high; Aches and pain; Felt sick; Dizzy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Back hurts - thinks it's her lungs), CHEST PAIN (Pain more in chest), CHEST DISCOMFORT (Chest pressure is worse/ Chest tightness), HYPERTENSION (Blood pressure high) and MYALGIA (Aches and pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder (The patient was on medication for thyroid which increases her heart rate - levothyroxine 75 mg.), Allergy (Allergic to just about everything), Asthma (She had major asthma - every time she watched TV she had to turn it off and use her inhaler.) and Borderline diabetes. Concomitant products included ASA and LEVOTHYROXINE for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced HYPERTENSION (Blood pressure high), MYALGIA (Aches and pain), VACCINATION COMPLICATION (Felt sick), DIZZINESS (Dizzy) and NAUSEA (Nauseous). On 26-Mar-2021, the patient experienced PULMONARY PAIN (Back hurts - thinks it's her lungs), CHEST PAIN (Pain more in chest), CHEST DISCOMFORT (Chest pressure is worse/ Chest tightness) and COUGH (Coughing all night long). On an unknown date, the patient experienced DYSPNOEA (Can't breath), BACK PAIN (Back hurts), NASOPHARYNGITIS (Cold-like symptoms) and SNEEZING (Sneezing). At the time of the report, PULMONARY PAIN (Back hurts - thinks it's her lungs), CHEST PAIN (Pain more in chest), CHEST DISCOMFORT (Chest pressure is worse/ Chest tightness), HYPERTENSION (Blood pressure high), MYALGIA (Aches and pain), VACCINATION COMPLICATION (Felt sick), DYSPNOEA (Can't breath), COUGH (Coughing all night long), BACK PAIN (Back hurts), DIZZINESS (Dizzy), NASOPHARYNGITIS (Cold-like symptoms), SNEEZING (Sneezing) and NAUSEA (Nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Blood pressure measurement: high (High) As soon as the shot was administered,her blood pressure was 192/120..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications also included inhaler and blood thinner.  The patient said that her blood pressure was high before the shot around 130/90 or 140/90.But after the shot it was 179/132.She went to ER on 23-MAR-2021,saw her primary doctor on 24-MAR-2021; Tests were done and was waiting on chest x-ray results.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received included additional events (cold-like symptoms and sneezing).
Patient was given Hep A and MCV4. Next day, arm red, warm to touch and swollen. Treated with warm compresses and cephalexin 500 mg cap by mouth 2 times a day for 10 days.
High pressure 140/73; Pounding in the head; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High pressure 140/73) and HEADACHE (Pounding in the head) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003F21A) for COVID-19 vaccination.     Concurrent medical conditions included Angioma. Concomitant products included DEXAMETHASONE for Angioma.    On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced HYPERTENSION (High pressure 140/73) and HEADACHE (Pounding in the head). At the time of the report, HYPERTENSION (High pressure 140/73) and HEADACHE (Pounding in the head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2021, Blood pressure measurement: 140/73 (High) High pressure 140/73. In October 2021, Heart rate: abnormal (abnormal) Uncomfortable heartbeat.         No treatment medications were reported.
Information has been received from a physician concerning a 19 day old male patient with hypospadias and a history of unconjugated hyperbilirubinemia, hypermagnesaemia, premature baby and no known drug allergies who on 16-SEP-2009 was vaccinated with a dose of RECOMBIVAX HB (Manufacturer unknown). Concomitant therapy included vitamins (unspecified) (POLY-VI-SOL) and ferrousSO4. On 26-SEP-2009 the patient was seen by a physician for vomiting after each feeding, wheezing and fussy. His physical examination revealed a 5.11 lb baby, and no other important finding. It was also reported that the baby had a projectile vomiting on 25-SEP-2009 at 3:00 pm. His appetite was normal and his stools were yellow (6 times) and clear like. The patient was diagnosed with gastrointestinal reflux (GER) and was prescribed with MYLICON and Ranitidine. The recommended diet was SIMILAC advance every two hours. On 30-SEP-2009, the patient was seen by a physician again for a follow up check. It was reported that the patient had fever (98.7 degrees F) on 29-SEP-2009. The patient continued vomiting after feeding and had diarrhea. His stools were yellow and not firm. His appetite was 3 oz every 3 hours. The patient's GER was better and NEOSURE was recommended. Additional information has been requested. All available medical records will be provided upon request.
Admitted with acute saddle PE with RV strain on 4/13/21, syncope, required TPA. LLE with acute DVT
Allegedly was administered a full dose of the vaccine instead of a booster; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Allegedly was administered a full dose of the vaccine instead of a booster) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Nov-2021 at 9:00 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced ACCIDENTAL OVERDOSE (Allegedly was administered a full dose of the vaccine instead of a booster). On 05-Nov-2021, ACCIDENTAL OVERDOSE (Allegedly was administered a full dose of the vaccine instead of a booster) had resolved.            No concomitant medication were reported. No treatment information was provided by the reporter.
Left shoulder pain without improvement since injection 9/13/2010. Decreased ROM to shoulder.
Patient started experiencing flu-like symptoms a day after his influenza vaccination. He noted that he experienced a very bad cough. About three weeks after vaccination he noticed that his "calves and feet" were swelling. He went to his MD and they stated that his kidneys were attacking themselves, some sort of "autoimmune disorder".  He is still experiencing problems.
burning sensation on her face and ears; burning sensation on her face and ears; she has been experiencing intense itching; This spontaneous report was received from a 77-year-old female consumer, referring to herself. The patient's pertinent medical history included asthma, glaucoma and gastrooesophageal reflux disease (GERD). Her concomitant therapies included fluticasone propionate (FLOVENT), ipratropium bromide (ATROVENT HFA), pantoprazole, diazepam and brimonidine tartrate. As previous drug reactions/allergies, the patient mentioned an unspecified penicillin, an unspecified sulfa and clarithromycin (BIAXIN).  On 06-MAR-2020, the patient was vaccinated with one shot of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) in the left upper arm, (strength, route of administration, vaccination scheme, lot number and expiration date were unknown), as prophylaxis.  On 06-MAR-2020, the patient experienced intense itching (pruritus), and burning sensation on her face and ears (burning sensation and ear discomfort). The patient sought medical attention as she spoke to the physician's office. As treatment, the patient had recommended diphenhydramine (benadryl). It was reported that the patient had a blood work performed due to the adverse events, however, no results were reported.  At the time of the report, the patient had not recovered from ear discomfort, pruritus and burning sensation. The causality assessment between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and the aforementioned events was not reported.
Information has been received from a 73 year old male patient with gastrooesophageal reflux disease who on 24-JUN-2009 was vaccinated with ZOSTAVAX (Merck). Secondary suspect therapy included pneumococcal vaccine (manufacturer unknown), polyval, (duration, dose and indication not reported). Concomitant therapy included ACIPHEX, LIPITOR, ECOTRIN, vitamins (unspecified) and PLAVIX. On 08-AUG-2002 the patient received a dose of PNEUMOVAX 23 (manufacturer unknown). On 23-JUL-2009 the patient was unable to visualize and dream after the administration of ZOSTAVAX (Merck). The patient's unable to visualize and dream persisted. On 25-JUL-2009, the patient was examined at the emergency room and was given a computed axial tomography scan which was negative. On 29-JUL-2009, the patient received a electrocardiogram which was also negative. The patient had not recovered. Upon internal review, the patient's unable to visualize was considered to be an other important medical event. Additional information has been requested.
Malaise, fever at onset. Sought help in ER 10/20/2013. No dx given. 10/23/2013, altered consciousness, probable meningitis or encephalitis.
After inj., felt weak within the first minute - site got red and swollen. Stayed swollen and red for 1 week. Hives on arm and body.
Patient had a pink face for a few seconds. The pinkness resolved when the patient sat down.
Information has been received through the Merck pregnancy registry and from a male consumer concerning his 22 year old wife with no known allergies or pertinent medical history who on 18-JUN-2007 was vaccinated with a dose of VARIVAX (Oka/Merck). Concomitant medication included prenatal vitamin. "About 12 days after vaccination" on approximately 30-JUN-2007 the patient became pregnant. Unspecified medical attention was sought. A urine test was performed. At the time of the report the patient was 6 1/2 weeks pregnant. No further information was provided. There was no product quality complaint involved. Outcome of the pregnancy was received. The patient performed ultrasound at 38 weeks (Approximately Mar 2008). The results confirmed oligohydramnios. On 25-MAR-2008 the patient delivered a normal, healthy male baby weighing 6 pounds 8 OZ. No further information is available.
Slight tingling sensation; Slight light headenest; Entire body ( head to toes ) became bright red; This case was reported by a consumer via call center representative and described the occurrence of tingling in a 79-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st November 2019, the patient received the 2nd dose of Shingrix. In November 2019, 2 weeks after receiving Shingrix, the patient experienced tingling, headache and erythema. On an unknown date, the outcome of the tingling, headache and erythema were unknown.   It was unknown if the reporter considered the tingling, headache and erythema to be related to Shingrix.  Additional details were received as follows: The patient about 2 week later after vaccination felt a slight tingling sensation and had a slight light headenest and entire body became bright red. The patient stated that had occurred 5 times. The 3rd time it occurred the patient went to a walk in clinic. The physician said there have been many reactions to the shot but he had not seen or heard of reaction. The patient concern was that after 2 months now still getting a reaction. The patient would like to know the thought regarding the events.
Swelling and itchiness in my toes mainly.  Fingers also exhibited the same symptoms but it was mild compared to how much my toes were itching.  This lasted about 4 days.  Also, my hair started falling out and hasn't stopped but not sure when this started but it wasn't like this before the vaccine.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site pain and injection site rash. On an unknown date, the outcome of the injection site pain and injection site rash were recovered/resolved. It was unknown if the reporter considered the injection site pain and injection site rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced severe pain and rash at the injection site. The reporter did not consent to follow-up. The reporter had limited information regarding the event and the health care professional did not want to follow up.
About a week after the second dose, I started getting neuropathy (tingling sensations/ pins and needles) in all 10 of my right fingers, the following week I noticed it in all 10 left fingers as well. By July 11th, I had neuropathy in all fingers and all toes. July 13th I visited an urgent care due to having blurry vision in the left eye. The Dr. was unable to diagnose and recommend I see a neurologist and ophthalmologist.   July 31st, I was taken to the E.R. due to lose of vision in right eye, loss of balance, neuropathy, and eye pain. I was then diagnosed with optic neuritis. After 4 MRIs and a lumbar puncture, the doctors diagnosed me with Multiple Sclerosis. I have no family history of MS, and the symptoms happened a week after the second dose and rapidly got worse.
Within minutes of shot, felt left cheek numbness and left eyelid felt off but resolved within the hour. For past week or so (vaccine 5/18, today 6/4) have felt random pins and needle stabs on my hands and feet. Past couple nights felt uncomfortable sensation bilateral lower legs that kept from being able to sleep, so walked around some before went away and could rest. This morning (6/4) woke and had right corner mouth spasms off and on for approximately 2 hours. (Unlikely due to low potassium as ate potato and banana night before).
Information has been received from a physician assistant concerning a 20 year old female with pertinent medical history reported as none and drug allergies not specified, who on 14-NOV-2007 was vaccinated with the first dose of GARDASIL (lot # 655154/1210U).  Concomitant therapy included YAZ.  The second dose of GARDASIL (lot # 655327/1287U) was given on 16-JAN-2008.  Between these two doses the patient gained 15 pounds.  The third dose of GARDASIL (lot # 0152X), was given on 07-MAY-2008.  Between the second and third dose the patient gained 25 pounds.  She gained a total of 40 pounds in about 5 to 6 months.  On an unspecified date, the patient sought medical attention by her primary care provider and had thyroid tests completed which were reported as negative.  At the time of reporting, the patient had not recovered.  No product quality complaint was involved.  Additional information has been requested.
4JAN94 mom of pt state pt recvd vax 30DEC93 & devel chills & fever (red face) 1JAN94 had h/a, mood swings, & crying from 530PM to 1030PM w/fever of 99; shaking, chills & couldn't breath; seen by MD;
Headache and chills/aches for 48 hours after second dose and than fine. Although one week later severe headache, chills, joint pains and fever
Pt with intrauterine fetal demise at 24 weeks and 3 days. 12/02/05
Initial report received on 22 July 2010 from a consumer, who is the patient's parent. A 4 month old female patient, with no medical history, received a second dose of ACTHIB (lot number UF976AA, which corresponds to sanofi pasteur SA lot number E0318-1) on 03 May 2010. Two to three hours post-vaccination, the patient began crying a high-pitched continuous cry for 1.5 hours. Afterward, the patient slept for six to seven hours and when she woke, she was dazed and cranky for the remainder of the day. The patient recovered. Of note, as captured in case 2010-03964, this patient previously experienced high-pitched crying, sleeping for six to seven hours, waking up dazed and cranky, and had projectile vomiting twice after receiving the first dose of ACTHIB and a dose of DAPTACEL on 25 February 2010.
little fever; Initial information received on 19-Jan-2021 regarding an unsolicited valid non-serious case received from a consumer.  This case involves patient (unknown demographics) who experienced little fever (pyrexia), while he/she received vaccine INFLUENZA VACCINE.  The patient had no medical history, concomitant disease or risk factor.  Medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious little fever (pyrexia) (next day) following the administration of INFLUENZA VACCINE  It was also reported that patient had shot had little fever next day been 7 days no side effects. They need to talk to someone who knows It is unknown if the patient experienced any additional symptoms/events.  There were no lab data/results available.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was reported as unknown.  There will be no information available on the batch number for this case.
On June 25th, 2022, Saturday at approximately 09:19am, patient was vaccinated with Pfizer Pediatric  0.20 ml I/M Left Arm.  Patient was then directed to Observation.  After a few minutes in Observation, it was reported to me that pt. was experiancing "Facial Muscle Spasms of the Mouth & Lips also causing an Involuntary Opening of the Lower Jaw" every few minutes.  Vital Signs were taken: HR 103; SpO2: 99RA; BP; 118/88; COAx4.  There were no life threating issues.  Pt remained in direct observation until 09:50am.  mother of patient informed me that she was bringing her daughter to a local Medical Center,  to see her Primary Care Physician.
Mild soreness at the injection site for a few days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mild soreness at the injection site for a few days) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 029L20A) for COVID-19 vaccination.     Patient had no allergies (medications, food and other products).  Patient had no COVID positive test or diagnosis in the past. Patient had not taken other vaccines within 1 month prior to Moderna COVID-19 vaccine.  Concomitant products included APIXABAN (ELIQUIS), PAROXETINE, MEMANTINE, BIMATOPROST (LUMIGAN), DORZOLAMIDE, VITAMIN D NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Mild soreness at the injection site for a few days). On 22-Feb-2021, VACCINATION SITE PAIN (Mild soreness at the injection site for a few days) had resolved.            No treatment medication was reported.   This case was linked to MOD-2022-558945, MOD-2022-559005.
High fever 103.4 chills body aches lightheaded dizzy fast heart rate no sleep it all came about around 11:30 pm on the 04/10/2021
Given Td Friday 07/05/02. Evening of 07/06/02 started with nausea, chills, feeling warm and "not right." 07/08/02 AM noticed 2x3" reddened, non-raised, slightly tender area approx 6" below injection site. No tenderness, swelling, etc at injection site.
Stomach issues/ stomach ailment; frequent bowel movements with very small amout of stools; Very tired; This is a spontaneous report from a contactable consumer, the patient. An unspecified aged male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on 02Apr2021 at 13:45 (age at vaccination was unknown) as a single dose for COVID-19 immunisation. Medical history included allergies (hay Fever). The patient had no known allergies to medications, food or other products. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), from an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Apr2021 at 19:30, the patient experienced very tired every day since vaccination, 3 days after vaccination (05Apr2021), the patient experienced stomach issues, (frequent bowel movements with very small amount of stools, as though he had a stomach ailment and was recovering from it. The patient felt much better after he ate something). No therapeutic measures were taken as a result of the reported events. The clinical outcomes of stomach issues, very tired and frequent bowel movements with very small amount of stools were recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Bivalent vaccine incorrectly administered for the primary series by RN.  Recognized immediately and mother of the patient notified.  Patient received first primary Pediatric Pfizer dose on 11/29/2022.
The reaction was a mild systemic reaction, and not severe.  He ought to be able to complete a full vaccination schedule.  However, there does not appear to be a way to document a mild, non-local, reaction without immediately contraindicating all future vaccines.
This spontaneous report as received from a pharmacist refers to a 60 years old female patient with allergies to LISINOPRIL (manufacturer unknown) (MARRS # 1210USA012644) and NSAID, who on 20-OCT-2012 was vaccinated subcutaneously with a dose of ZOSTAVAX (1 vial) (lot number H0125778 in process of validation, expiration date 28-SEP-2013). No other co-suspects were reported. Concomitant medications included levothyroxine sodium and losartan potassium (manufacturer unknown). The pharmacist reported that the patient developed redness at the injection site after receiving a dose of ZOSTAVAX. No treatment information was reported. At the time of the report, the patient was recovering from the adverse event. The patient sought medical attention: saw the pharmacist. No laboratory tests were performed. The relatedness for the adverse event was unknown for ZOSTAVAX. Additional information has been requested.